These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 11987143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V, Chi G.
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R, Sanchez T, Clement O, Shoemaker R, Sei S, Neamati N.
    J Med Chem; 2005 Jan 13; 48(1):111-20. PubMed ID: 15634005
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C, Bailly F, Cotelle P.
    Curr Med Chem; 2003 Sep 13; 10(18):1795-810. PubMed ID: 12871105
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P, Guiguen A, Cauvin C, Georges B, Le Van K, Michaux C, Cardona C, Mbemba G, Mouscadet JF, Hevesi L, Van Lint C, Wouters J.
    Eur J Med Chem; 2011 May 13; 46(5):1749-56. PubMed ID: 21385662
    [Abstract] [Full Text] [Related]

  • 14. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.
    AIDS Rev; 2009 May 13; 11(1):17-29. PubMed ID: 19290031
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T, Yoshinaga T, Sato A, Yodo M, Fujiwara T, Kiyama R.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8430-45. PubMed ID: 17010623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG, Dierynck I, Amssoms KI, Hu L, Boonants PM, Pille GM, Daeyaert FF, Hertogs K, Surleraux DL, Wigerinck PB.
    J Med Chem; 2005 Mar 24; 48(6):1930-40. PubMed ID: 15771437
    [Abstract] [Full Text] [Related]

  • 19. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
    Witvrouw M, Debyser Z.
    Verh K Acad Geneeskd Belg; 2003 Mar 24; 65(5):325-34. PubMed ID: 14671848
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.